TL;DR
This study reveals a novel mechanism by which HPV16 oncoprotein E7 drives cervical cancer. It shows that E7 interacts with and disrupts the function of the long noncoding RNA HOTAIR, a key regulator of gene silencing. This disruption leads to altered gene expression patterns that promote cancer development and metastasis, offering potential new avenues for diagnosis and treatment.
What Problem Does This Paper Address?
Cervical cancer is a major global health concern, with high-risk Human Papillomavirus (HPV) types, particularly HPV16, being the primary cause. The HPV16 oncoprotein E7 is known to be a critical driver of this cancer by inactivating host regulatory molecules. However, the precise molecular mechanisms by which E7 orchestrates such widespread cellular changes, especially concerning epigenetic regulation, remain incompletely understood. Specifically, the role of long noncoding RNAs (lncRNAs) like HOTAIR, which are known to influence chromatin structure and gene expression, in this process was unclear. This paper investigates how E7 might interact with and modulate HOTAIR to promote cervical carcinogenesis.
Methods
The researchers employed a multi-pronged approach:
- Gene Expression Analysis: They used quantitative reverse transcription PCR (qRT-PCR) to measure the expression levels of HOTAIR, HPV16 E7, HOXD10 (a known HOTAIR target), and PRC2 complex members (EZH2 and SUZ12) in clinical samples (HPV-negative controls, HPV16-positive non-malignants, and HPV16-positive cervical cancer cases).
- Cell Line Studies: They transfected an HPV-negative cervical cancer cell line (C33A) with the HPV16 E7 gene to observe the effects on HOTAIR and PRC2 member expression. They also analyzed expression in HPV16-positive cell lines (SiHa and Caski).
- In Silico Prediction: They used computational tools (RPI-Seq and catRAPID) to predict potential physical interactions between HOTAIR and HPV16 E7.
- RNA-Immunoprecipitation (RIP): This technique was used to experimentally confirm the physical interaction between HOTAIR and HPV16 E7 in cell lines.
- Microarray Analysis: Global gene expression profiling was performed on a subset of samples to identify differentially expressed genes and pathways associated with different HOTAIR expression levels in cervical cancer.
- Statistical Analysis: Various statistical tests, including t-tests, ANOVA, and correlation analyses, were used to assess the significance of observed differences and relationships.
Datasets
The study utilized clinical samples from:
- HPV-negative cervical tissue samples (controls).
- HPV16-positive non-malignant cervical tissue samples.
- HPV16-positive cervical cancer (CaCx) tissue samples.
These samples were characterized for HPV status, viral load, and physical status of the HPV16 genome (episomal vs. integrated). Additionally, the HPV-negative cervical cancer cell line C33A, and HPV16-positive cell lines SiHa and Caski were used.
Key Insights and Ideas
- HOTAIR as a potential target of E7: The study's central hypothesis was that HPV16 E7 might target HOTAIR. The observed down-regulation of HOTAIR in HPV16-positive cases, particularly in cancer, and its correlation with E7 expression, strongly supports this.
- Two distinct mechanisms of E7-mediated gene regulation: The research proposes two ways E7 might disrupt HOTAIR's function:
- Low HOTAIR levels: In cases with low HOTAIR, there's reduced recruitment of the PRC2 complex, leading to less gene silencing.
- E7-HOTAIR competition: In cases with high HOTAIR and high E7, E7 might directly compete with PRC2 for binding sites on HOTAIR, also preventing effective gene silencing.
- HOTAIR's role in metastasis: A subset of cervical cancer cases with high HOTAIR expression showed enrichment of pathways related to cell movement and metastasis, suggesting HOTAIR's involvement in the aggressive nature of some tumors.
- E7's influence on PRC2 complex members: E7 expression was found to be positively correlated with the expression of PRC2 components (EZH2 and SUZ12), indicating that E7 might upregulate these key epigenetic regulators, which are normally recruited by HOTAIR.
Key Results
- A significant linear trend of progressive HOTAIR down-regulation was observed from HPV-negative controls to HPV16-positive non-malignants and then to CaCx samples.
- A subset of CaCx cases (15.89%) showed significant HOTAIR up-regulation (48.5-fold in LH cases compared to HPV negative controls), while the majority (84.11%) showed down-regulation (6.77-fold).
- HOTAIR expression was positively and significantly correlated with HPV16 E7 expression in clinical samples and in E7-transfected C33A cells.
- HOXD10, a target gene of HOTAIR, showed significant up-regulation in CaCx cases, and its expression was negatively correlated with HOTAIR expression in cancer samples.
- Global gene expression profiling revealed distinct patterns between low and high HOTAIR expressing CaCx cases, with high HOTAIR cases showing enrichment of pathways related to cell movement and metastasis.
- EZH2 and SUZ12 were overexpressed in CaCx cases and their expression correlated with HPV16 E7 expression.
- In silico analysis and RNA-Immunoprecipitation confirmed a physical interaction between HPV16 E7 and HOTAIR.
Limitations and Future Work
- Clinical correlation: The study notes a lack of association between HOTAIR levels (LH or HH) and tumor stage or histopathological grades. This might be due to the homogeneous nature of the studied CaCx samples (mostly SCCs, stage III and above). Further studies are needed to explore this.
- Mechanism of HOTAIR regulation by E7: While a correlation and physical interaction were shown, the precise molecular mechanism by which E7 down-regulates HOTAIR (e.g., through miRNAs like miR-34a) requires experimental validation.
- In silico validation: The predicted binding sites for E7 within HOTAIR require further experimental validation.
- Therapeutic potential: The findings suggest HOTAIR could be a potential diagnostic marker and that understanding its interplay with E7 might lead to new therapeutic strategies. Further research into chromatin immunoprecipitation and deep sequencing (ChIP-Seq) is planned to delineate gene sets with altered silencing and activation marks.
Summary updated